secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pyxis Oncology, Inc. (PYXS)
CIK:        0001782223
Form:       8-K
Filed at:   2024-02-28T23:59:59+00:00
Accession:  0000950170-24-021643
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pyxis Oncology raises ~$50M in private placement of shares and pre-funded warrants
--------------------------------------------------------------------------------

- Gross proceeds of ~$50M from 8.85M shares at $4.78 and pre-funded warrants for 1.61M shares at $4.779.
- Participants include Deep Track Capital, Ridgeback Capital, Blue Owl Healthcare, Laurion Capital, and StemPoint Capital.
- Proceeds to fund development of lead ADC candidate PYX-201 for solid tumors and for working capital.
- Private placement expected to close on or about Feb 29, 2024; registration statement to be filed by Mar 27, 2024.
- Leerink Partners serving as lead placement agent; LifeSci Capital as co-placement agent.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1782223/000095017024021643/0000950170-24-021643-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1782223/000095017024021643/pyxs-20240226.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-021643

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer